According to Telix Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.30338. At the end of 2023 the company had a P/S ratio of 6.56.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.56 | -55.1% |
2022 | 14.6 | -96.76% |
2021 | 451 | 99.16% |
2020 | 226 | 101.05% |
2019 | 113 | -84.51% |
2018 | 727 |